- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4295EUR$4,500USD£3,598GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe
From €1432EUR$1,500USD£1,199GBP
- Report
- October 2024
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2625EUR$2,750USD£2,199GBP
- Report
- December 2021
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3340EUR$3,500USD£2,799GBP
The Mononucleosis Test is a type of infectious disease test used to diagnose mononucleosis, also known as glandular fever. It is typically used to detect the presence of antibodies to the Epstein-Barr virus, which is the most common cause of mononucleosis. The test is usually performed on a blood sample, and results are typically available within a few days. The test is often used to diagnose mononucleosis in people who have symptoms such as fever, sore throat, swollen lymph nodes, and fatigue.
The Mononucleosis Test market is a subset of the larger Infectious Disease Testing market, which includes tests for a wide range of infectious diseases. The Mononucleosis Test market is driven by the increasing prevalence of mononucleosis, as well as the need for accurate and timely diagnosis.
Some companies in the Mononucleosis Test market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, and Roche Diagnostics. Show Less Read more